Top segments and regional performance

Last year, the company generated ‪1.55 M‬ USD, the most of which — ‪1.55 M‬ USD — came from its top-performing segment, Cardiovascular Medicines, compared to ‪1.00 M‬ USD the previous year. The greatest contribution came from Canada, which accounted for ‪1.55 M‬ USD last year, with ‪1.00 M‬ USD the year before.